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Abstract: This study aims to develop an amperometric glucose biosensor, based on carbon 
nanotubes material for reverse iontophoresis, fabricated by immobilizing a mixture of glucose 
oxidase (GOD) and multiwalled carbon nanotubes (MWCNT) epoxy-composite, on a planar 
screen-printed carbon electrode. MWCNT was employed to ensure proper incorporation into 
the epoxy mixture and faster electron transfer between the GOD and the transducer. Results 
showed this biosensor possesses a low detection potential (+500 mV), good sensitivity 
(4 µA/mM) and an excellent linear response range (r2 = 0.999; 0–4 mM) of glucose detection 
at +500 mV (versus Ag/AgCl). The response time of the biosensor was about 25 s. In addition, 
the biosensor could be used in conjunction with reverse iontophoresis technique. In an actual 
evaluation model, an excellent linear relationship (r2 = 0.986) was found between the glucose 
concentration of the actual model and the biosensor’s current response. Thus, a glucose 
biosensor based on carbon nanotube composites and incorporated with reverse iontophoresis 
function was developed.
Keywords: amperometric, carbon nanotubes, glucose monitoring, biosensors, reverse 
iontophoresis
Introduction
The discovery of carbon nanotube (CNT) in 1991, led to many new technical 
developments and applications because of the characteristics of large surface area, 
unique electronic properties, and relatively high mechanical strength associated with it.1 
Recent studies demonstrated high electrocatalytic effect and fast electron-transfer rate 
in CNT material2–6 and thereby provide a new material for fabricating biosensors.7,8 
Moreover, CNT can reduce the surface fouling on electrochemical devices without 
a mediator. The ability of CNT in facilitating electron transfer of hydrogen peroxide 
(H
2
O
2
) shows great promise as oxidase-based amperometric biosensors.6,9 To the 
best of our knowledge there is no report on the use of CNT composites in glucose 
biosensor, incorporated with reverse iontophoresis function, for noninvasive glucose 
monitoring.
Reverse iontophoresis is a technique using a small electric charge to extract 
both charged and neutral molecules through the skin, recently used for patient 
monitoring.10–15 The authors only found reports of a glucose sensor integrated with 
reverse iontophoresis function.11,14–30 This glucose biosensor, approved by the US 
Food and Drug Administration, is GlucoWatch® biographer, which passes a small 
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current between two skin-surface hydrogel electrodes to 
extract glucose-containing interstitial fluid into hydrogel 
pads, incorporating a glucose oxidase (GOD) biosensor.14,17,31 
Unfortunately, GlucoWatch causes several problems, such 
as skin irritation or rash under the device in a number of 
patients. This problem may be due to the immobilization 
of GOD inside the hydrogel pads releasing peroxide. Even 
worse, GlucoWatch is unreliable in detecting hypoglycemia 
and hyperglycemia.16
The aim of this study is thus to find out the optimum 
combination of multiwalled carbon nanotubes and GOD 
for a glucose biosensor, in order to develop a new glucose 
biosensor incorporated with reverse iontophoresis function 
for noninvasive glucose monitoring. The glucose biosensor 
for reverse iontophoresis was eventually evaluated in this 
study.
Materials and methods
Reagents and solutions
All reagents used in this study, were commercially available 
and used without further purification: GOD (type VII), β–D(+) 
glucose, phosphate buffered saline, multiwalled carbon 
nanotubes (MWCNT, 0.5–50 µm, .95% purity) powders 
were purchased from Sigma Chemical Co. (St. Louis, MO, 
USA); Methylcellulose (MC, Methocel A4M Prem) from 
Dow Chemical Co. (Midland, MI, USA). Deionized water 
purified by a Millipore System (Milli-Q UFplus; Bedford, 
MA, USA) was used to prepare all solutions. Graphite paste, 
silver paste, silver-silver chloride (Ag/AgCl) paste, and 
insulating paste were purchased from Advanced Conductive 
Materials (Atascadero, CA, USA). Epoxy (EPO-TEK® 
509FM-1) was purchased from Epoxy Technology (Billerica, 
MA, USA). Polyethylene terephthalate (PETE) sheet was 
purchased from 3M.
Construction of the glucose biosensor
The construction steps of a planar three-electrode transducer 
were shown schematically in Figure 1, according to the 
procedure described earlier.32 The transducer was then used 
for glucose biosensor construction.
A biocomposite paste was prepared by mixing MWCNT 
(18.0%–19.5% w/w) with GOD (0.5%–2.0% w/w), followed 
by the incorporation of epoxy (80.0% w/w) and further 
30 minutes mixing, in order to obtain a homogeneous bio-
composite paste. This paste (10 µL) was then coated onto 
the surface of a graphite pad (working electrode) of the 
transducer and dried for 3 days at 30°C. Unused glucose 
biosensors were kept in the dark at 4°C.
Hydrodynamic voltammetry 
measurements of the glucose biosensor
Using an electrochemical interface (electrochemical 
interface SI1286, Schlumberger Technologies, England), 
measurements were taken at 25°C with the biosensor in 
a solution of 4 mM glucose in 0.1 M phosphate buffer 
(pH 7.0) subjected to constant stirring. Incremental poten-
tials (0–1000 mV, 100 mV increments) versus Ag/AgCl 
pad were applied to the working electrode of the biosensor 
and the current responses of the biosensor to glucose were 
measured.
(a) (b) (c) (d) (e)
Figure 1 Construction steps for the planar configuration of the screen-printed transducer. a) (PETE) support material; b) conducting silver basal track; c) insulation layer; 
d) Ag/AgCl pads, the iontophoresis electrode (the central circular one) for reverse iontophoresis and the reference electrode; e) graphite pads, the working and counter 
electrodes.
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Measurements of the biosensor  
current response to glucose
Measurements were carried out at 25°C at the electrochemical 
interface. The biosensor was placed in a cell containing 0.1 M 
phosphate buffer solution pH 7.0, subjected to constant 
stirring, employed as supporting electrolyte. An applied 
potential of +500 mV versus Ag/AgCl pad was applied to 
the working electrode of the biosensor. After the background 
current stabilized, different glucose solution was added to the 
constantly-stirred buffer solution and the current response of 
the biosensor to glucose was then measured.
Evaluation of the ferrocene-mediated 
glucose biosensor for reverse 
iontophoresis
A 90 µL of a 4% MC gel (prepared by mixing 4 g of MC 
with 100 mL of 0.1 M phosphate buffer pH 7.0) was laced 
onto two biosensors made up of optimum combination of 
MWCNT (18.0% w/w) and GOD (2.0% w/w). The two 
biosensors were then fixed onto the nanoporous membrane 
(Spectra/Por® CE, MWCO: 500, Spectrum Laboratories, 
Inc., Canada) of our custom-developed diffusion cell,33 filled 
with different concentrations of glucose solutions, and the 
iontophoresis electrode center of the biosensors was 23 mm 
apart. Using our custom-developed reverse iontophoresis 
device34 at room temperature (22–24°C), a bipolar current 
(0.3 mA/cm2, period = 30 minutes, ie, 555.6 µHz) was passed 
between the iontophoresis electrodes for 90 minutes. At the 
end of the experiment, biosensors were connected to the 
electrochemical interface for current response measurement 
and an applied potential of +500 mV versus Ag/AgCl pad 
was applied to the working electrode.
Results and discussion
The amperometric transducer
Good inert behavior of the counter electrode is very 
important and hence elements such as gold and platinum 
are commonly used.35,36 On the other hand, there is no 
report of any meaningful relationship between current 
density and the materials used and their geometries.37 
Therefore graphite, an inert material, was used as counter 
electrode material in this study based on their availability 
and affordability.
The ratio of counter electrode area to working electrode 
area (A
C
/A
W
), can exert influence on the supply of determined 
current to the working electrode without limiting its 
response.38 The optimal A
C
/A
W
 ratio was reported to be in 
the range of 1 and 12.39–43 Composite material used in this 
study allows fabrication of an inert graphite counter electrode 
with an A
C
/A
W
 ratio of at least 0.125. Furthermore, there is 
no great difference between the current density of transducer 
constructed with A
C
/A
W
 ratio 0.11 and 9.20.37 Therefore 
the A
C
/A
W
 ratio of 1 was employed on constructing the 
amperometric transducer in this study.
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Figure 2 Hydrodynamic voltammogram of the biosensors in constantly-stirred solution of 4 mM glucose with 0.1 M phosphate buffer (pH 7.0).
Abbreviations: GOD, glucose oxidase; MWCNT, multiwalled carbon nanotubes.
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Hydrodynamic voltammogram  
of the glucose biosensor
Several reports7,8 have suggested that carbon nanotube can 
significantly facilitates catalytic effect, both on the reduction 
and oxidation of hydrogen peroxide (H
2
O
2
), making it 
highly sensitive in detection of H
2
O
2
. Figure 2 illustrated 
the hydrodynamic voltammogram of the biosensors at 
a constantly-stirred solution of 4 mM glucose in 0.1 M 
phosphate buffer (pH 7.0). It was found that the oxidation 
currents generated by the biosensors begin at potential about 
+500 mV. Carbon nanotube therefore can significantly 
facilitate the electron transfer between H
2
O
2
 molecules.7,8 
Moreover, carbon nanotube promotes the low oxidation 
potential amperometric determination of glucose. As shown 
in Figure 2, biosensor with the combination of MWCNT 
(18.0% w/w) and GOD (2.0% w/w) is optimal for detecting 
and generating glucose signals, than mixture with other 
ratios.
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Figure 3 Current-time curve obtained by successive addition of 4 mM glucose solution to the biosensor. Data is obtained from biosensor with the combination of MWCNT 
(18.0% w/w) and GOD (2.0% w/w).
Abbreviations: GOD, glucose oxidase; MWCNT, multiwalled carbon nanotubes.
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Figure 4 Calibration curves of the biosensors to glucose concentration. The lines are best fit found by linear regression. Sensitivity of the biosensor is indicated by the slope 
of the linear regression line.
Abbreviations: GOD, glucose oxidase; MWCNT, multiwalled carbon nanotubes.
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Calibration of the biosensor to glucose
Figure 3 showed a current-time curve, where steps 
correspond to current response of the biosensor (MWCNT 
[18.0% w/w] and GOD [2.0% w/w] mixture) at the applied 
potential of +500 mV, for successive additions of 4 mM 
glucose in 0.1 M phosphate buffer solution (pH 7.0). 
Immediately after the addition of glucose solution, the 
reductive current increased and reached 95% of the steady 
state current at about 25 seconds. The response time of 
our biosensor is comparable to that reported by Antiochia 
and Gorton.44
From the data of current-time curves, the magnitude 
of current response was plotted against the glucose 
concentration (see Figure 4) and the sensitivity of the 
biosensor was determined by the slope of linear regression 
of this current response versus glucose concentration. 
The current response is directly proportional to the 
glucose concentration over a wide range of concentration 
(0–4 mM), where correlation coefficient is greater than 
0.997. Since the amount of transdermal glucose extraction 
by reverse iontophoresis is in the order of µM,28 the range of 
measurement of glucose biosensor designed in this study can 
detect the normal concentrations of transdermally extracted 
glucose with good accuracy.
Biosensor constructed with MWCNT (18.0% w/w) and GOD 
(2.0% w/w), as shown in Figure 4, has the greatest sensitivity 
of 4.0 µA/mM, more than 1.36 times the other biosensors. 
Therefore, the combination of 18.0% w/w of MWCNT and 
2.0% w/w of GOD is considered as the optimum combination 
for constructing glucose biosensor in this study.
The reproducibility in the construction of the biosensor 
was evaluated from standard deviation of biosensor sensi-
tivity. As shown in Table 1, the relative standard deviation 
of biosensor sensitivity indicated a batch reproducibility of 
biosensor construction of about 4% (n = 5).
Although the glucose biosensor of the GlucoWatch has a 
linear (r2 ~ 0.98) glucose response range of 0–28 mM which 
is larger than the one in this study (r2 ~ 1.00, 0–4 mM), 
the amount of transdermal glucose extraction by reverse 
iontophoresis are several orders of magnitude lower than 
those present in the blood (~5 µM vs ~ 5 mM).28 Therefore, 
our glucose biosensor can cover the concentrations of the 
transdermally extracted glucose and be useful in a clinical 
setting.
Table 1 The sensitivity (n = 5) of the biosensor at different 
combinations of glucose oxidase (GOD) loading and multiwalled 
carbon nanotubes (MWCNT) loading
Biosensor MWCNT  
(%)
GOD  
(%)
Sensitivity  
(µA/mM)
Relative 
SD
1 18.0 2.0 4.13 ± 0.14 3.4%
2 18.5 1.5 3.02 ± 0.11 3.6%
3 19.0 1.0 2.05 ± 0.07 3.4%
4 19.5 0.5 2.01 ± 0.08 4.0%
y = 0.1201× + 0.6449
R2 = 0.9858
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Figure 5 Evaluation of the biosensor for noninvasive glucose measurement by reverse iontophoresis. An excellent linear relationship (r2 = 0.986) between the biosensor 
current response and glucose concentration in diffusion cell was found. Data (n = 5) was obtained from biosensor with the optimum combination of MWCNT (18.0% w/w) 
and GOD (2.0% w/w). The diffusion cell was filled with an electrolyte solution comprising 0.1 M phosphate buffer (pH 7.0) and 3–15mM glucose.
Abbreviations: GOD, glucose oxidase; MWCNT, multiwalled carbon nanotubes.
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The use of the biosensor for noninvasive 
glucose measurement by reverse 
iontophoresis
The biosensor, with the optimum combination of MWCNT 
(18.0% w/w) and GOD (2.0% w/w), coupled to our 
custom-developed reverse iontophoresis device34 has been 
tested in this study. Transmembrane (the membrane of the 
diffusion cell) glucose extraction, achieved by means of the 
reverse iontophoresis, was then quantified by the biosensor. 
The magnitude of the biosensor current response was plotted 
against the glucose concentration inside the diffusion cell 
(see Figure 5). In order to simulate hypoglycemia, normal 
and hyperglycemia situations, glucose concentrations of 
3 mM, 5 mM and 15 mM was chosen respectively for testing 
inside the diffusion cell. An excellent linear relationship 
(r2 = 0.99) was found between the diffusion cell glucose 
concentration (3–15 mM) and biosensor current response. 
Based on the results, our glucose biosensor was accu-
rate enough to be used to measure glucose levels in both 
condition of hypoglycemia and hyperglycemia, as opposed 
to GlucoWatch®’s unreliability in detecting hypoglycemia 
and hyperglycemia.45
Conclusion
A simple, low-cost carbon nanotube composite-based 
glucose biosensor with low oxidation potential and high 
sensitivity was developed in this study. The use of the biosen-
sor incorporated with reverse iontophoresis for noninvasive 
glucose determination at glucose range for hypoglycemia, 
normal and hyperglycemia situations were also demonstrated 
to be successful and potentially useful in clinical setting, 
better than the presently commercialized product.
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